UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives Review article
2023
Authors:  Ye, Zi Han;  Yu, Wei Bang;  Huang, Mu Yang;  Chen, Jun;  Lu, Jin Jian
Favorite | TC[WOS]:9 TC[Scopus]:10  IF:14.7/14.1 | Submit date:2023/05/02
Bispecific Antibodies  Cancer  Cd47  Clinical Data  Combination Strategies  Future Perspectives  Mechanisms  Preclinical Data  
Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives Journal article
Ye,Zi Han, Yu,Wei Bang, Huang,Mu Yang, Chen,Jun, Lu,Jin Jian. Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives[J]. Acta Pharmaceutica Sinica B, 2023, 13(4), 1467-1487.
Authors:  Ye,Zi Han;  Yu,Wei Bang;  Huang,Mu Yang;  Chen,Jun;  Lu,Jin Jian
Favorite | TC[WOS]:9 TC[Scopus]:10  IF:14.7/14.1 | Submit date:2023/08/03
Bispecific Antibodies  Cancer  Cd47  Clinical Data  Combination Strategies  Future Perspectives  Mechanisms  Preclinical Data  
Anti-cancer effects of polyphenols via targeting p53 signaling pathway: updates and future directions Journal article
Haroon Khan, Marcella Reale , Hammad Ullah, Antoni Sureda, Silvia Tejada, Ying Wang, Zhang-Jin Zhang, Jianbo Xiao. Anti-cancer effects of polyphenols via targeting p53 signaling pathway: updates and future directions[J]. BIOTECHNOLOGY ADVANCES, 2020, 38, 107385.
Authors:  Haroon Khan;  Marcella Reale ;  Hammad Ullah;  Antoni Sureda;  Silvia Tejada; et al.
Favorite | TC[WOS]:106 TC[Scopus]:118  IF:12.1/14.6 | Submit date:2021/03/02
Anticancer  Chemoresistance  Clinical Perspectives  P53 Signaling Pathways  Polyphenols